MARKET

BMY

BMY

Bristol-Myers Squibb Co
NYSE
44.70
-4.16
-8.51%
After Hours: 44.90 +0.2 +0.45% 17:35 04/25 EDT
OPEN
47.39
PREV CLOSE
48.86
HIGH
47.50
LOW
44.37
VOLUME
45.04M
TURNOVER
0
52 WEEK HIGH
70.94
52 WEEK LOW
44.37
MARKET CAP
90.60B
P/E (TTM)
11.57
1D
5D
1M
3M
1Y
5Y
Bristol-Myers Squibb Stock: Gloomy Q1 Earnings Trigger Justified Sell-Off
Bristol-Myers Squibb's Q1 2024 quarterly earnings release has resulted in a drop in its share price of 8%. BMY's market cap valuation is lower than competitors such as Vertex and Regeneron. Wall Street is bearish on BMY due to concerns about its portfolio, pipeline, and prospects.
Seeking Alpha · 2h ago
Health Care Sector Update for 04/25/2024: LAB, PRGO, BMY, AZN
NASDAQ · 2h ago
UPDATE 1-S&P 500 first-qtr earnings outlook improves this week -LSEG
U.S. First-quarter earnings growth estimate for S&P 500 has improved in recent days. Year-over-year growth for the first quarter of 2024 is seen at 4.3%, up from 3.3% this week. But disappointing forecasts from Meta Platforms have offset some of the optimism.
Reuters · 2h ago
Crude Oil Moves Higher; Bristol Myers Squibb Shares Fall After Q1 Results
U.S. Stocks traded lower toward the end of trading on Thursday. The Dow traded down 1.20% while the Nasdaq Composite fell by around 100 points. Bristol Myers Squibb & Co. Shares fell more than 8% after posting a loss in the first quarter. Impinj, Inc. Shares shot up 26% after reporting better-than-expected first-quarter financial results. Asian markets closed mostly higher in Asia Pacific markets.
Benzinga · 3h ago
Biotech Stock Roundup: BIIB, BMY's Q1 Earnings, INCY's Acquisition & Updates from VRTX
NASDAQ · 3h ago
Bristol-Myers Squibb Co reports results for the quarter ended in March - Earnings Summary
Bristol-Myers Squibb Co reports results for the quarter ended in March. The company reported a quarterly adjusted loss of $4.40 per share. Revenue rose 4.7% to $11.87 billion from the same quarter last year. Bristol- myers squibb shares have fallen by 9.9% this quarter.
Reuters · 3h ago
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Caterpillar Inc. Fell 6.6% to $339.37 on Thursday. Caterpillar reported better-than-expected first-quarter EPS but missed revenue estimates. Barfresh Food Group, Inc. Shares surged 87.2% after the company reported better than expected results. Chicken Soup for the Entertainment for the Soul Entertainment dropped 75%.
Benzinga · 4h ago
BUZZ-U.S. STOCKS ON THE MOVE-Loar, Regeneron, Intel
U.S. Stocks slumped on Thursday. Dow Jones Industrial Average was down 1.15% and the S&P 500 was down 0.76%. Most megacaps fell after Meta Platforms' quarterly results. Newmont Corp. Was the top percentage gainer on the NYSE and the Nasdaq.
Reuters · 4h ago
More
About BMY
Bristol-Myers Squibb Company is a biopharmaceutical company engaged in the discovery, development and delivering advanced medicines that help patients prevail over serious diseases. It offers products for various therapeutic classes, which includes oncology, hematology, immunology, cardiovascular and neuroscience. Its pharmaceutical products include chemically synthesized or small molecule drugs, products produced from biological processes, called biologics and chimeric antigen receptor (CAR-T) cell therapies. Small molecule drugs are typically administered orally in the form of a tablet or capsule, although other drug delivery mechanisms are used as well. Biologics are administered to patients through injections or by intravenous infusion. Its in-line products include Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Yervoy, Sprycel, Reblozyl, Opdualag, Abecma, Zeposia, and others. The Company's product pipeline includes Krazati, MRTX1719, RYZ101, KarXT, ORM-6151, and Repotrectinib.

Webull offers Bristol-Myers Squibb Co stock information, including NYSE: BMY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BMY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BMY stock methods without spending real money on the virtual paper trading platform.